Evaluating hydronidone for the treatment of chronic hepatitis B-associated liver fibrosis
, 2025-04-18 18:57:00 Background and aims Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis showed that adding hydronidone to entecavir resulted in…